Stockreport

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]

Nanobiotix S.A. - ADSs  (NBTX) 
PDF Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and neck cancer; initial efficacy and favorable safety profile supports potential of [Read more]